HomeTGTX • NASDAQ
add
TG Therapeutics Inc common stock
Previous close
$29.03
Day range
$28.21 - $29.28
Year range
$25.28 - $46.48
Market cap
4.67B USD
Avg Volume
1.63M
P/E ratio
10.57
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 192.57M | 78.00% |
Operating expense | 103.94M | 65.41% |
Net income | 23.04M | -1.26% |
Net profit margin | 11.96 | -44.55% |
Earnings per share | 0.14 | -6.67% |
EBITDA | 50.52M | 68.62% |
Effective tax rate | 48.91% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 141.97M | -54.35% |
Total assets | 1.06B | 84.05% |
Total liabilities | 415.23M | 16.86% |
Total equity | 648.02M | — |
Shares outstanding | 147.68M | — |
Price to book | 6.42 | — |
Return on assets | 12.09% | — |
Return on capital | 14.31% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 23.04M | -1.26% |
Cash from operations | 19.66M | 176.67% |
Cash from investing | -15.64M | -199.05% |
Cash from financing | 1.06M | 117.42% |
Net change in cash | 5.08M | 131.90% |
Free cash flow | 19.93M | 164.80% |
About
Founded
1993
Headquarters
Website
Employees
399
